Integrative colloidal gels for cranial defect repair

用于颅骨缺损修复的一体化胶体凝胶

基本信息

  • 批准号:
    8433328
  • 负责人:
  • 金额:
    $ 35.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-01 至 2016-02-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The long-term objective of this application is to deliver a unique biomaterial that can easily be molded into place by a surgeon, and will resorb as it induces rapid tissue regeneration. Toward this objective, we invented a biomaterial based on colloidal gel technology, which we have demonstrated to be effective in calvarial defect regeneration. The key feature that distinguishes colloidal gels from the two major classes of scaffolding biomaterials (hydrogels and solid scaffolds) is their paste-like rheology, which in turn is attributed to electrostatic interaction of the nanoparticle constituents. Although this new class of scaffolds is highly versatile in its unbounded combination of possible synthetic and natural nanoparticles, we have elected to focus on a combination of naturally occurring materials with controlled release of bioactive signals. Therefore, the objective of this project is to develop a malleable material that can be spread into place in a cranial defect, while releasing bioactive factors and allowing native bone to penetrate and resorb the material. The corresponding central hypothesis is that the growth factor-loaded colloidal gels will regenerate bone in cranial defects significantly faster and more completely than unloaded colloidal gels or commercial hydroxyapatite bone fillers. To test this hypothesis, we propose three specific aims: 1) to synthesize and characterize novel colloidal gels with modulated rheological properties, 2) to engineer and refine colloidal gels in vitro, and 3) to determine the efficacy of colloidal gels in a rat cranial defect model. Building on our published characterization of prototype colloidal gels, our overall strategy will be to significantly expand our repertoire first by evaluating the rheological and release properties of a variety of combinations of specific sulfated glycosaminoglycans (GAGs, negatively charged) and hydroxyapatite nanoparticles (positively charged), which have been identified as an internally cohesive colloidal gel network. A specific subset of these combinations will then be thoroughly evaluated in vitro for their efficacy in promoting osteogenesis with rat bone marrow-derived mesenchymal stem cells (BMSCs). The most promising groups from these in vitro studies will be evaluated in critical-sized rat calvarial defects, with the project thereby culminating in the identification of the leading combination of GAGs, hydroxyapatite, and osteogenic and angiogenic signals for calvarial defect regeneration. Successful completion of this project will lay the foundation for an entirely new sub-field for tissue engineering scaffolding biomaterials. The true impact of this line of research is its extraordinary versatility and relatively straightforward set of design principles as a means to create bioresorbable, pastes of tunable consistency, with the capability for controlled release of bioactive signals. We and other investigators world- wide will be able to explore a seemingly infinite number of innovative combinations of interactive nanoparticles for applications beyond calvarial defect regeneration, from osteochondral regeneration to liver regeneration to any other conceivable application where such a material is desired.
描述(由申请人提供):本申请的长期目标是提供一种独特的生物材料,该材料可由外科医生轻松模制到位,并在诱导快速组织再生时吸收。为了实现这一目标,我们发明了一种基于胶体凝胶技术的生物材料,我们已经证明它在颅骨缺损再生中是有效的。胶体凝胶区别于两大类支架生物材料(水凝胶和固体支架)的关键特征是它们的糊状流变性,这又归因于纳米颗粒成分的静电相互作用。虽然这类新的支架在其可能的合成和天然纳米颗粒的无限组合方面具有高度的通用性,但我们选择专注于天然材料与生物活性信号的受控释放的组合。因此,本项目的目标是开发一种可延展的材料,该材料可以在颅骨缺损中扩散到位,同时释放生物活性因子并允许天然骨穿透和吸收材料。相应的中心假设是,与未加载的胶体凝胶或商业羟基磷灰石骨填充物相比,加载生长因子的胶体凝胶将显著更快且更完全地再生颅骨缺损中的骨。为了验证这一假设,我们提出了三个具体的目标:1)合成和表征新的胶体凝胶与调制的流变性能,2)工程和完善胶体凝胶在体外,和3)确定胶体凝胶在大鼠颅骨缺损模型的疗效。基于我们已发表的原型胶体凝胶的表征,我们的总体策略将是首先通过评估特定硫酸化糖胺聚糖(GAG,带负电荷)和羟基磷灰石纳米颗粒(带正电荷)的各种组合的流变学和释放特性来显着扩展我们的库,这些组合已被确定为内部内聚胶体凝胶网络。这些组合的一个特定子集,然后将在体外彻底评估其在促进大鼠骨髓间充质干细胞(BMSC)的成骨作用。这些体外研究中最有前途的组将在临界大小的大鼠颅骨缺损中进行评估,该项目最终确定了用于颅骨缺损再生的GAG、羟基磷灰石以及成骨和血管生成信号的主要组合。 该项目的成功完成将为组织工程支架材料这一全新的研究领域奠定基础。这一系列研究的真正影响是其非凡的多功能性和相对简单的设计原则,作为一种手段来创建生物可吸收的,可调一致性的糊剂,具有控制释放生物活性信号的能力。我们和世界各地的其他研究人员将能够探索看似无限数量的相互作用纳米颗粒的创新组合,用于颅骨缺损再生以外的应用,从骨软骨再生到肝再生,再到任何其他需要这种材料的可想象的应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Cory Berkland其他文献

Cory Berkland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Cory Berkland', 18)}}的其他基金

Preparing BBI-001 as an oral, non-absorbed iron chelator for prevention of iron overload
将 BBI-001 制备为口服非吸收铁螯合剂,用于预防铁过载
  • 批准号:
    10258539
  • 财政年份:
    2021
  • 资助金额:
    $ 35.71万
  • 项目类别:
Engineering Microparticles for Taste-Masking and Controlled Release of Pediatric
用于儿科药物掩味和控释的工程微粒
  • 批准号:
    8396082
  • 财政年份:
    2012
  • 资助金额:
    $ 35.71万
  • 项目类别:
Precision Particle Fabrication-enabled Betamethasone-loaded Microspheres for Tran
用于 Tran 的精密颗粒制造负载倍他米松的微球
  • 批准号:
    8396087
  • 财政年份:
    2012
  • 资助金额:
    $ 35.71万
  • 项目类别:
Integrative colloidal gels for cranial defect repair
用于颅骨缺损修复的一体化胶体凝胶
  • 批准号:
    8239401
  • 财政年份:
    2012
  • 资助金额:
    $ 35.71万
  • 项目类别:
Targeted nanoscale antigen arrays for treating autoimmune diseases
用于治疗自身免疫性疾病的靶向纳米级抗原阵列
  • 批准号:
    8513574
  • 财政年份:
    2012
  • 资助金额:
    $ 35.71万
  • 项目类别:
Integrative colloidal gels for cranial defect repair
用于颅骨缺损修复的一体化胶体凝胶
  • 批准号:
    8804184
  • 财政年份:
    2012
  • 资助金额:
    $ 35.71万
  • 项目类别:
Integrative colloidal gels for cranial defect repair
用于颅骨缺损修复的一体化胶体凝胶
  • 批准号:
    8607930
  • 财政年份:
    2012
  • 资助金额:
    $ 35.71万
  • 项目类别:
Multi-day Pain Management Therapy with Novel Injectable Formulation
采用新型注射制剂的多日疼痛管理疗法
  • 批准号:
    8198342
  • 财政年份:
    2011
  • 资助金额:
    $ 35.71万
  • 项目类别:
Expanding Precision Particle Fabrication Technology for the Widespread Control of
扩展精密粒子制造技术以实现广泛控制
  • 批准号:
    7908631
  • 财政年份:
    2010
  • 资助金额:
    $ 35.71万
  • 项目类别:
Expanding Precision Particle Fabrication Technology for the Widespread Control of
扩展精密粒子制造技术以实现广泛控制
  • 批准号:
    8089561
  • 财政年份:
    2010
  • 资助金额:
    $ 35.71万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 35.71万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 35.71万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了